Movement Alert｜Twist Bioscience Corp Rises 5.06% in Regular Trading, AI Pharma Sector Momentum and Eli Lilly Collaboration Continue to Drive Gains

Market Focus09-19

On September 18, Twist Bioscience Corp rose 5.06% in regular trading, trading at $163.43/share, with turnover of $208 million, extending its recent strong rally.

On the news front, the company recently announced a collaboration with Eli Lilly's AI/ML drug discovery platform Lilly TuneLab, providing antibody characterization data services to accelerate antibody drug discovery. Notably, GenScript and Ginkgo Bioworks also joined the platform on the same day, signaling an accelerating shift in the AI pharma value chain from molecular design toward wet-lab validation. At the Baird Global Healthcare Conference, management disclosed that fiscal Q4 revenue is expected at approximately $124 million, representing roughly 25% year-over-year growth and exceeding the FactSet consensus estimate of $117.4 million. AI pharma-related orders have reached $50 million and are projected to double to $100 million next year. Additionally, the company was previously selected by Anthropic as an independent evaluator for an AI protein design project, a catalyst that had driven a single-day surge of over 17%, with cumulative gains exceeding 50% since August.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1170764976?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-19 03:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1170764976","market":"us","top_or_hot":-1,"title":"Movement Alert｜Twist Bioscience Corp Rises 5.06% in Regular Trading, AI Pharma Sector Momentum and Eli Lilly Collaboration Continue to Drive Gains","media":"Market Focus","content":"<p><p>On September 18, Twist Bioscience Corp rose 5.06% in regular trading, trading at $163.43/share, with turnover of $208 million, extending its recent strong rally.</p><p>On the news front, the company recently announced a collaboration with Eli Lilly's AI/ML drug discovery platform Lilly TuneLab, providing antibody characterization data services to accelerate antibody drug discovery. Notably, GenScript and Ginkgo Bioworks also joined the platform on the same day, signaling an accelerating shift in the AI pharma value chain from molecular design toward wet-lab validation. At the Baird Global Healthcare Conference, management disclosed that fiscal Q4 revenue is expected at approximately $124 million, representing roughly 25% year-over-year growth and exceeding the FactSet consensus estimate of $117.4 million. AI pharma-related orders have reached $50 million and are projected to double to $100 million next year. Additionally, the company was previously selected by Anthropic as an independent evaluator for an AI protein design project, a catalyst that had driven a single-day surge of over 17%, with cumulative gains exceeding 50% since August.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Twist Bioscience Corp Rises 5.06% in Regular Trading, AI Pharma Sector Momentum and Eli Lilly Collaboration Continue to Drive Gains</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Twist Bioscience Corp Rises 5.06% in Regular Trading, AI Pharma Sector Momentum and Eli Lilly Collaboration Continue to Drive Gains\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-09-19 03:29</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On September 18, Twist Bioscience Corp rose 5.06% in regular trading, trading at $163.43/share, with turnover of $208 million, extending its recent strong rally.</p><p>On the news front, the company recently announced a collaboration with Eli Lilly's AI/ML drug discovery platform Lilly TuneLab, providing antibody characterization data services to accelerate antibody drug discovery. Notably, GenScript and Ginkgo Bioworks also joined the platform on the same day, signaling an accelerating shift in the AI pharma value chain from molecular design toward wet-lab validation. At the Baird Global Healthcare Conference, management disclosed that fiscal Q4 revenue is expected at approximately $124 million, representing roughly 25% year-over-year growth and exceeding the FactSet consensus estimate of $117.4 million. AI pharma-related orders have reached $50 million and are projected to double to $100 million next year. Additionally, the company was previously selected by Anthropic as an independent evaluator for an AI protein design project, a catalyst that had driven a single-day surge of over 17%, with cumulative gains exceeding 50% since August.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TWST","symbol_name":"Twist Bioscience Corp","start_time":0,"source_url":"","article_id":"1170764976","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1170764976","pubTimestamp":1789759755,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On September 18, Twist Bioscience Corp rose 5.06% in regular trading, trading at $163.43/share, with turnover of $208 million, extending its recent strong rally.On the news front, the company...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TWST":"Twist Bioscience Corp"},"translate_title":"走势提醒|Twist Bioscience Corp 常规交易中上涨 5.06%，人工智能制药板块势头和礼来合作继续推动上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TWST":1},"content_text":"On September 18, Twist Bioscience Corp rose 5.06% in regular trading, trading at $163.43/share, with turnover of $208 million, extending its recent strong rally.On the news front, the company recently announced a collaboration with Eli Lilly's AI/ML drug discovery platform Lilly TuneLab, providing antibody characterization data services to accelerate antibody drug discovery. Notably, GenScript and Ginkgo Bioworks also joined the platform on the same day, signaling an accelerating shift in the AI pharma value chain from molecular design toward wet-lab validation. At the Baird Global Healthcare Conference, management disclosed that fiscal Q4 revenue is expected at approximately $124 million, representing roughly 25% year-over-year growth and exceeding the FactSet consensus estimate of $117.4 million. AI pharma-related orders have reached $50 million and are projected to double to $100 million next year. Additionally, the company was previously selected by Anthropic as an independent evaluator for an AI protein design project, a catalyst that had driven a single-day surge of over 17%, with cumulative gains exceeding 50% since August.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1170764976","isCrawlerRequest":true}